ERBB2 and neoplasm: Forty percent of these mice had evidence of leptomeningeal disease when tumors were delivered intraventricularly, which responded to HER2 CAR T treatment, allowing these mice with LMD similar degree of tumor response and survival as mice with parenchymal tumors alone.